全文获取类型
收费全文 | 68105篇 |
免费 | 4355篇 |
国内免费 | 161篇 |
专业分类
耳鼻咽喉 | 636篇 |
儿科学 | 2409篇 |
妇产科学 | 1745篇 |
基础医学 | 9789篇 |
口腔科学 | 667篇 |
临床医学 | 7430篇 |
内科学 | 14791篇 |
皮肤病学 | 1444篇 |
神经病学 | 6828篇 |
特种医学 | 1813篇 |
外国民族医学 | 31篇 |
外科学 | 7646篇 |
综合类 | 410篇 |
一般理论 | 38篇 |
预防医学 | 6281篇 |
眼科学 | 1142篇 |
药学 | 4358篇 |
中国医学 | 121篇 |
肿瘤学 | 5042篇 |
出版年
2023年 | 430篇 |
2022年 | 310篇 |
2021年 | 1350篇 |
2020年 | 875篇 |
2019年 | 1518篇 |
2018年 | 2059篇 |
2017年 | 1448篇 |
2016年 | 1520篇 |
2015年 | 1722篇 |
2014年 | 2091篇 |
2013年 | 3205篇 |
2012年 | 5086篇 |
2011年 | 5063篇 |
2010年 | 2657篇 |
2009年 | 2155篇 |
2008年 | 4344篇 |
2007年 | 4567篇 |
2006年 | 4392篇 |
2005年 | 4323篇 |
2004年 | 4045篇 |
2003年 | 3714篇 |
2002年 | 3622篇 |
2001年 | 1267篇 |
2000年 | 1278篇 |
1999年 | 1093篇 |
1998年 | 441篇 |
1997年 | 340篇 |
1996年 | 277篇 |
1995年 | 302篇 |
1994年 | 252篇 |
1993年 | 272篇 |
1992年 | 624篇 |
1991年 | 548篇 |
1990年 | 525篇 |
1989年 | 495篇 |
1988年 | 460篇 |
1987年 | 415篇 |
1986年 | 381篇 |
1985年 | 358篇 |
1984年 | 279篇 |
1983年 | 230篇 |
1982年 | 153篇 |
1980年 | 125篇 |
1979年 | 188篇 |
1978年 | 130篇 |
1974年 | 133篇 |
1973年 | 122篇 |
1972年 | 122篇 |
1971年 | 126篇 |
1969年 | 135篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
Nicolas Zhou Matthew Bott Bernard J. Park Eric Vallières Candice L. Wilshire Kazuhiro Yasufuku Jonathan D. Spicer David R. Jones Boris Sepesi 《The Journal of thoracic and cardiovascular surgery》2021,161(3):760-771.e2
BackgroundAdjuvant chemotherapy, postoperative radiation (PORT), and prophylactic cranial irradiation (PCI) have been individually examined in limited-stage small cell lung cancer (SCLC). There is a paucity of data on the effectiveness of each adjuvant treatment modality when used in combination after surgical resection of SCLC.MethodsData were collected from 5 cancer centers on all patients with limited-stage SCLC who underwent surgical resection between 1986 and 2019. Univariate and multivariable models were conducted to identify predictors of long-term outcomes, focusing on freedom from recurrence and survival benefit of adjuvant chemotherapy, PORT, and PCI.ResultsA total of 164 patients were analyzed. Multivariable Cox regression analysis did not identify any adjuvant therapies to significantly influence recurrence in this cohort. Specifically, PORT was not associated with a significant influence on locoregional recurrence and PCI was not significantly associated with intracranial outcomes. Adjuvant chemotherapy improved survival in all stage I through III disease (hazard ratio, 0.49; 95% confidence interval, 0.29-0.81; P = .005) and even in pathologically node negative patients (hazard ratio, 0.49; 95% confidence interval, 0.27-0.91; P = .024). Although PCI was found to improve survival in univariate analysis, it was not significant in a multivariable model. PORT was not found to affect survival on either univariate or multivariable analysis.ConclusionsThis is among the largest multi-institutional studies on surgically resected limited-stage SCLC. Our results highlight survival benefit of adjuvant chemotherapy, but did not identify a statistically significant influence from mediastinal PORT or PCI in our cohort. Larger prospective studies are needed to determine the benefit of PORT or PCI in a surgically resected limited-stage SCLC population. 相似文献
4.
Cécile Q.T. Nguyen Marie-Hélène Denis Miguel Chagnon Rémi Rabasa-Lhoret Geneviève Mailhot 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2021,31(1):277-285
Background and aimsDeterioration of anthropometric and lung function parameters was shown to precede the onset of cystic fibrosis-related diabetes (CFRD) in adults. In children, studies have been conducted in small cohorts with relatively short observation period. Study objectives were to document the longitudinal trends of anthropometric, pulmonary, nutritional and metabolic parameters from cystic fibrosis (CF) diagnosis to the ascertainment of abnormal glucose tolerance and identify parameters associated with the incidence of such abnormalities in a pediatric CF cohort.Methods and resultsRetrospective cohort study of 281 children with CF. Longitudinal trends of anthropometric, lung function, nutritional and metabolic data were generated from CF diagnosis to the ascertainment of abnormal glucose tolerance defined as the presence of either impaired glucose tolerance (IGT), unconfirmed CFRD or CFRD. Cox models and Kaplan–Meier curves were used to identify factors associated with developing abnormal glucose tolerance.Forty-five percent of cohort had normal glucose tolerance (NGT), 27% IGT, 10% unconfirmed CFRD and 18% CFRD. Children who developed CFRD displayed lower height z-scores from a very early age. Conversely, HbA1c levels began to rise closer to CFRD ascertainment. Height z-scores (HR: 0.45; CI 95% [0.29–0.69]) and HbA1c (HR: 2.43; CI 95% [1.86–3.18]) in years preceding ascertainment were associated with the risk of developing CFRD.ConclusionChildren who developed CFRD display distinctive trends for height z-scores from a very early age, whereas HbA1c appears as a marker of established glucose metabolism derangements. 相似文献
5.
6.
7.
8.
9.
10.